Soolantra is a gentle treatment formulated to fight rosacea. Clinically proven to be effective — in a 12-week clinical trial, subjects using soolantra saw:
– A reduction in symptoms in 2 weeks
– Continued improvement through the course of the yearlong study
Important Safety Information
Indication: SOOLANTRA® (ivermectin) Cream, 1% is indicated for the treatment of inflammatory lesions of rosacea. Not for oral, ophthalmic or intravaginal use.
Adverse Events: In clinical trials with SOOLANTRA Cream, the most common adverse reactions (incidence ≤1%) included skin burning sensation and skin irritation.